Epstein Secrets

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Steffen Klusmann Editor-in-Chief The Financial Times Germany Deutschland Hermann-Josef Knipper Deputy Editor-in-Chief Handelsblatt Germany Carsten Knop Senior Business Editor Frankfurter Allgemeine Germany Zeitung Sir Nigel Knowles Managing Partner DLA Piper UK LLP United Kingdom Eizo Kobaya

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

Steffen Klusmann Editor-in-Chief The Financial Times Germany Deutschland Hermann-Josef Knipper Deputy Editor-in-Chief Handelsblatt Germany Carsten Knop Senior Business Editor Frankfurter Allgemeine Germany Zeitung Sir Nigel Knowles Managing Partner DLA Piper UK LLP United Kingdom Eizo Kobaya

John K. Defterios John J. DeGioia Alain Dehaze Jeffrey Deitch Marijn E. Dekkers Michael S. Dell Chris

Akira Kiyota Stephan Klapproth Katherine Klein Klaus Kleinfeld Andrzej Klesyk Hans Klingenberg Lutz Knappmann John Knight Edward S. Knight Carsten Knop Klaas Knot Sir Nigel Knowles Teresa Ko Tomas Ko Freitag de Lara Chief Executive Officer and Executive Vice-Chairman Group General Manager; Co

tlev Engel Klaus Engel Richard P. Eno David R. Epstein Mary Callahan Erdoes Charles W. Ergen Paula Esco

ra Kiyota Larry Klane Bruce Klein Klaus Kleinfeld Mark Kleinman Andrzej Klesyk Hans Klingenberg Jurgen Kluge Steffen Klusmann Hermann-Josef Knipper Carsten Knop Sir Nigel Knowles Eizo Kobayashi Yoshimitsu Kobayashi Aaron Koblin General Manager and Editor-in-Chief Senior Vice-President, Industrial Relation